I have done seminal studies in three areas of research that have now moved to clinical trials in the last 3 years. I carried out first ever studies in signal transduction through the interleukin-6 receptor in Idiopathic Pulmonary Fibrosis (IPF). In addition, for the first time ever, used stem cells from the human umbilical cord and human placental amnion cells to treat animal models of lung diseases. The latter has led to clinical trials in treating premature babies with bronchopulmonary dysplasia in Melbourne.